SCHEMBL5752932

SCHEMBL5752932

CCOC(=O)c1c(-c2ccccc2)oc(COC)c1-c1ccc(F)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
GAA P10253 3/20 0.49
KDM4E B2RXH2 7/20 0.47
ALDH1A1 P00352 7/20 0.47
HPGD P15428 6/20 0.47
TP53 P04637 1/20 0.47
NPSR1 Q6W5P4 3/20 0.46
MAPT P10636 3/20 0.46
NPC1 O15118 1/20 0.46
LMNA P02545 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
PTGS2 P35354 3/20 0.44
PRNP P04156 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
GRM6 O15303 1/20 0.42
THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5754159 0.90 MEN1 (0.48) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL5748965 0.88 MEN1 (0.47) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL5749187 0.87 ANO1 (0.44) KDM4EALDH1A1HPGDTP53
SCHEMBL3907147 0.85 ALDH1A1 (0.51) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL22730883 0.75 ALDH1A1 (0.60) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL2402345 0.71 MEN1 (0.60) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL18781917 0.71 MAPT (0.65) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL29858565 0.71 ALDH1A1 (0.53) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL2400434 0.70 MEN1 (0.59) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL2402436 0.70 MEN1 (0.55) MEN1KMT2AGAAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6982348-B2 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-01-03 US disclosed
US-20040127574-A1 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-07-01 US disclosed
EP-1362846-A1 AMINOETHANOL DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127574-A1 Aminoethanol derivatives CETP, LCAT, MTTP MEN1 2847/4885KMT2A 404/4885GAA 3065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.